1. Repositório Institucional da UFMG
  2. Publicações Científicas e Culturais
  3. Artigo de Periódico
Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/63456
Full metadata record
DC FieldValueLanguage
dc.creatorAlice Machado-Silvapt_BR
dc.creatorDanielle Passos-Silvapt_BR
dc.creatorRobson Augusto Souza dos Santospt_BR
dc.creatorRubén Dario Sinisterra Millánpt_BR
dc.date.accessioned2024-01-29T14:05:40Z-
dc.date.available2024-01-29T14:05:40Z-
dc.date.issued2016-
dc.citation.volume26pt_BR
dc.citation.issue6pt_BR
dc.citation.spage669pt_BR
dc.citation.epage678pt_BR
dc.identifier.doihttps://doi.org/10.1080/13543776.2016.1179283pt_BR
dc.identifier.issn1744-7674pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/63456-
dc.description.resumoIntroduction: Angiotensin-(1-7) is a key component of the Renin-Angiotensin System, which can counter-regulate several deleterious effects caused by angiotensin II. Due to the potential for therapeutic use, several of its actions are specifically described in patents. Areas covered: In this review, the authors describe a plethora of therapeutic uses for Angiotensin-(1-7), claimed and supported by experimental evidence in patent documents and applications. Expert opinion: The clinical potential of Angiotensin-(1-7) as a therapeutic agent to treat several pathologies is evidenced by the variety of patents and clinical trials involving this peptide. Cancer treatment is one of the most advanced therapeutic areas, but clinical studies are also available in several other areas, such as cardiovascular, hematological, transplantation, surgical and medical procedures.pt_BR
dc.description.sponsorshipCNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológicopt_BR
dc.description.sponsorshipFAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Geraispt_BR
dc.description.sponsorshipINCT – Instituto nacional de ciência e tecnologia (Antigo Instituto do Milênio)pt_BR
dc.description.sponsorshipOutra Agênciapt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentICB - DEPARTAMENTO DE FISIOLOGIA E BIOFÍSICApt_BR
dc.publisher.departmentICX - DEPARTAMENTO DE QUÍMICApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofExpert Opinion on Therapeutic Patentspt_BR
dc.rightsAcesso Restritopt_BR
dc.subjectAngiotensin (1-7)pt_BR
dc.subjectArg0pt_BR
dc.subjectMas receptorpt_BR
dc.subjectPanCytept_BR
dc.subjectTXA-127pt_BR
dc.subjectRASpt_BR
dc.subject.otherAngiotensina - Uso terapêuticopt_BR
dc.subject.otherSistema renina-angiotensinapt_BR
dc.subject.otherPatentespt_BR
dc.subject.otherCâncer - Tratamentopt_BR
dc.titleTherapeutic uses for Angiotensin-(1-7)pt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://www.tandfonline.com/doi/full/10.1080/13543776.2016.1179283pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-7656-1849pt_BR
Appears in Collections:Artigo de Periódico

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.